English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Medicines Company
Nicholas Gueguen
| Aug 22, 2017
The Medicines Company releases progress report for second quarter
Nicholas Gueguen
| Jul 22, 2017
ORION-1 Phase II data shows promise for inclisiran
Caitlin Nordahl
| Apr 22, 2017
The Medicines Company to highlight its antimicrobial products at conference in Austria
Gene Johnson
| Apr 10, 2017
Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
Kyle Perrotti
| Mar 15, 2017
Conference call to review study of inclisiran
Gene Johnson
| Mar 10, 2017
FDA accepts The Medicines Co.'s filing for urinary tract infection drug
Erianne Leatherman
| Mar 3, 2017
FDA accepts priority application for urinary tract infection treatment
Keri Carbaugh
| Jan 10, 2017
Meanwell presents at Morgan Healthcare Conference
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
Patient Daily
| Aug 21, 2025
Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
